Nathalie Nicolaiew
Overview
Explore the profile of Nathalie Nicolaiew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blanc C, Moktefi A, Jolly A, De La Grange P, Gay D, Nicolaiew N, et al.
Br J Cancer
. 2022 Dec;
128(5):918-927.
PMID: 36550208
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate cancer (PCa) that has become a major challenge in clinics. Understanding the neuroendocrine differentiation (NED) process at the molecular...
2.
Terry S, El-Sayed I, Destouches D, Maille P, Nicolaiew N, Ploussard G, et al.
Oncotarget
. 2019 Jul;
10(41):4247-4248.
PMID: 31289621
[This corrects the article DOI: 10.18632/oncotarget.2740.].
3.
Terry S, Nicolaiew N, Basset V, Semprez F, Soyeux P, Maille P, et al.
Cancer
. 2015 Feb;
121(9):1422-30.
PMID: 25639219
Background: In view of the marked molecular heterogeneity of prostate cancer (PCa), clinical and pathologic parameters alone may be unreliable for predicting disease outcomes after surgical intervention. The development of...
4.
Terry S, El-Sayed I, Destouches D, Maille P, Nicolaiew N, Ploussard G, et al.
Oncotarget
. 2015 Jan;
6(14):11994-2008.
PMID: 25596738
Members of the EGF-CFC (Cripto, FRL-1, Cryptic) protein family are increasingly recognized as key mediators of cell movement and cell differentiation during vertebrate embryogenesis. The founding member of this protein...
5.
Terry S, Maille P, Baaddi H, Kheuang L, Soyeux P, Nicolaiew N, et al.
Neoplasia
. 2013 Jul;
15(7):761-72.
PMID: 23814488
Castration-resistant prostate cancers (CRPCs) that relapse after androgen deprivation therapies (ADTs) are responsible for the majority of mortalities from prostate cancer (PCa). While mechanisms enabling recurrent activity of androgen receptor...
6.
Ploussard G, Nicolaiew N, Marchand C, Terry S, Allory Y, Vacherot F, et al.
BJU Int
. 2013 Mar;
111(6):988-96.
PMID: 23452046
Unlabelled: WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Even after a negative set of prostate biopsies, the risk of undetected prostate cancer remains clinically significant. Predictive...
7.
Nicolaiew N, Ploussard G, Chun F, Xylinas E, Allory Y, Salomon L, et al.
Urol Int
. 2013 Jan;
90(3):306-11.
PMID: 23295308
Objective: We aimed to build a nomogram allowing to predict the probability of prostate cancer (PC) after an initial 21-core biopsy and with readily available clinical data. Methods: 1,490 screened...
8.
Ploussard G, Nicolaiew N, Marchand C, Terry S, Vacherot F, Vordos D, et al.
Eur Urol
. 2012 Jun;
65(1):154-61.
PMID: 22698576
Background: The debate on the optimal number of prostate biopsy core samples that should be taken as an initial strategy is open. Objective: To prospectively evaluate the diagnostic yield of...
9.
Ploussard G, Durand X, Xylinas E, Moutereau S, Radulescu C, Forgue A, et al.
Eur Urol
. 2010 Dec;
59(3):422-9.
PMID: 21156337
Background: The optimal selection of prostate cancer (PCa) patients for active surveillance (AS) is currently being debated. Objective: To assess the impact of urinary prostate cancer antigen 3 (PCA3) score...
10.
Ploussard G, Terry S, Maille P, Allory Y, Sirab N, Kheuang L, et al.
Cancer Res
. 2010 Nov;
70(22):9253-64.
PMID: 21045157
Expression of class III β-tubulin (βIII-tubulin) correlates with tumor progression and resistance to taxane-based therapies for several human malignancies, but its use as a biomarker of tumor behavior in prostate...